HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

New Yumizen G coagulation analyzers and reagent range designed to suit any laboratory

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents. Marking a milestone in its new product development program, the Yumizen G range extends HORIBA Medical’s Hematology portfolio into the complementary field of Haemostasis, a new discipline for the company.

One of HORIBA Medical’s new Hemostasis range – the Yumizen G400 is designed for small laboratories to perform coagulation screening and D-dimer tests

For over 30 years, HORIBA Medical has developed a reputation for expertise and excellence in blood cell analysis. This scientific knowledge, innovation, leadership and cutting-edge technology has now been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

HORIBA Medical’s new Yumizen G systems are user friendly, efficient and secure. In combination with specifically developed and optimized ready-to-use reagents, Yumizen G provides a high quality and cost-effective range of hemostasis solutions that will fit any laboratory size or requirement. The range includes:

  • Yumizen G100 INR, the smallest analyzer of the range, ideal for point of care laboratories to monitor oral anticoagulants
  • Yumizen G200 & Yumizen G400 compact semi-automatic devices designed to enable small laboratories to perform coagulation screening and D-dimer tests
  • Yumizen G800 automatic benchtop coagulation analyser for laboratories with mid-size workloads
  • Yumizen G1550 fully-automated, high capacity analyzer for managing the coagulation diagnostics and monitoring requirements of clinical laboratories with mid- to high-workloads

Commenting on the launch of this comprehensive new coagulation analysis offering, Cleve Wright, Director, HORIBA Medical UK said:

By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline. This means that HORIBA Medical is now able to offer customers a dedicated and specific blood analysis solution to suit any laboratory. We will be further building on our new Hemostasis product range in the very near future.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    HORIBA Medical. (2019, June 19). HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio. News-Medical. Retrieved on December 23, 2024 from https://www.news-medical.net/news/20180511/HORIBA-Medical-introduces-new-Yumizen-G-range-to-extend-Hematology-portfolio.aspx.

  • MLA

    HORIBA Medical. "HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio". News-Medical. 23 December 2024. <https://www.news-medical.net/news/20180511/HORIBA-Medical-introduces-new-Yumizen-G-range-to-extend-Hematology-portfolio.aspx>.

  • Chicago

    HORIBA Medical. "HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio". News-Medical. https://www.news-medical.net/news/20180511/HORIBA-Medical-introduces-new-Yumizen-G-range-to-extend-Hematology-portfolio.aspx. (accessed December 23, 2024).

  • Harvard

    HORIBA Medical. 2019. HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio. News-Medical, viewed 23 December 2024, https://www.news-medical.net/news/20180511/HORIBA-Medical-introduces-new-Yumizen-G-range-to-extend-Hematology-portfolio.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HORIBA's Microsemi CRP analyzer improves quality of care in emergency pediatric units, study shows